News
9,320 News Articles
Apr
03
2024
San José del Pacifico Is Still the Magic Mushroom Capital of Mexico - Thrillist
It would be my first-ever psilocybin trip, but given where I'd found myself—how could I not oblige?
Apr
03
2024
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance
BETR-001 is BetterLife's proprietary 2-bromo-LSD, a non-hallucinogenic derivative of lysergic acid diethylamide (LSD). The IND-enabling cardio- ...
Apr
03
2024
Psilocybin for the people - The Commons
Lauren Alderfer, PhD, is the author of Mindful Microdosing: A Guidebook and Journal, published by Green Writers Press, available on Amazon.
Apr
03
2024
Alberta Pioneers Insurance Coverage for Psychedelic-Assisted Therapy - The Dales Report
Alberta Blue Cross leads in insurance coverage for psychedelic therapy, marking a pivotal change in mental health treatment access.
Apr
03
2024
BetterLife Announces Closing of $1.168 Million Convertible - GlobeNewswire
... LSD-based Drug Candidate BETR-001 ... BETR-001 is BetterLife's proprietary 2-bromo-LSD, a non-hallucinogenic derivative of lysergic acid diethylamide ( ...
Apr
02
2024
Compass Pathways to participate in upcoming 23rd Annual - GlobeNewswire
We are also conducting phase 2 clinical studies of COMP360 psilocybin therapy for post-traumatic stress disorder (PTSD) and anorexia nervosa. Compass ...
Apr
02
2024
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP ...
... psilocybin and MDMA, is pleased to announce that three validation batches of its Natural Psilocybin Extract have undergone full release testing ...
Psilocybin
Apr
02
2024
PsyCan Welcomes Expansion of Insurance Coverage for Psychedelic-Assisted Therapy in Alberta
Psycan announces that Blue Cross Alberta has issued a notice to prescribers that it will reimburse patients for Psychedelic-Assisted Therapy...
Apr
02
2024
Research Findings Promising as Scientists Study Placebo Effect in Psychedelic Treatment
... psychedelic treatments in comparison to conventional treatments. ... psychedelics and the latest developments and advances in the psychedelics sector.
Apr
02
2024
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP ...
... psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is pleased to announce that ...
Psilocybin
Apr
02
2024
Optimi Health Advances Psilocybin Extract to Market - TipRanks.com
Optimi Health Corp. (TSE:OPTI) has released an update. Optimi Health Corp., a leader in psychedelics pharmaceuticals, has achieved a milestone by ...
Psilocybin
Apr
02
2024
Massachusetts Lawmakers Consider Psychedelics Therapy Legalization Bill | High Times
A Massachusetts joint legislative committee held a hearing to consider a proposal to legalize the therapeutic use of certain natural psychedelics.
Psychedelics
Apr
02
2024
Magic mushrooms: A new frontier in diabetes treatment? - PsyPost
... psilocybin, could play a role in combating the effects of diabetes. According to their preliminary research, published in the journal Genes, ...
Apr
02
2024
Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine ...
... evaluating the safety and feasibility of oral psilocybin as a potential treatment for methamphetamine use disorder conducted under an invest.
Psilocybin
Apr
01
2024
Challenges of acute pain management in older patients | Age and Ageing | Oxford Academic
Nebulised ketamine hold promises as alternative to opioids with potentially fewer side effects, offering a valuable option for older adults where ...
Apr
01
2024
Applications of Untargeted Chemical Analysis to Determine Psilocybin and Psilocin Content ...
In this interview, Kevin Schug discusses his work using untargeted analysis and differentiation of psilocybin mushroom strains.
Psilocybin
Apr
01
2024
Ketamine - Drishti IAS
Ketamine · Ketamine is a medication primarily used for inducing anaesthesia and sedation in medical settings. · While ketamine shows promise in treating ...
Ketamine
Mar
29
2024
Concerns raised around legalizing psychedelic mushrooms for therapy - Advantage News
State Sen. Bill Cunningham, D-Chicago, raised concerns about the proposed Compassionate Use and Research of Entheogens Act. The legislation would ...
Mar
29
2024
Editorial: Medicare benefit should ease seniors' health-cost burden - Sentinel and Enterprise
Therapeutic psychedelics' pros, cons aired at legislative hearing. The mushroom crowd descended on the State House earlier this week, seeking ...
Mar
29
2024
Naropa University Launches Pioneering Psychedelic Minor - Yahoo Finance
New Program Prepares Undergraduate Students to Support Emerging Need for Psychedelic Therapy Facilitation in Colorado and Beyond.
Mar
29
2024
Researchers Find New Way To Measure Potency of Mushrooms | High Times
... Psychedelics · Home Psychedelics Researchers Find New Way To Measure Potency of Mushrooms. News · Psychedelics. Researchers Find New Way To Measure ...
Psychedelics
Mar
29
2024
Naropa University Launches Pioneering Psychedelic Minor | News | bakersfield.com
... psychedelic-assisted therapies, is now launching one of the first psychedelic minor programs in the country for undergraduate students of all majors.
Mar
29
2024
Your Highness' CEO Becky Rotramel Champions Women In Cannabis - Forbes
I cover the cannabis industry, psychedelics, culture, and innovation. ... Its designs blend psychedelic artwork with nostalgia: think cartoons, skull ...
Cannabis
Mar
29
2024
(PDF) Producing Altered States of Consciousness, Reducing Substance Misuse - ResearchGate
... psychedelic substance (here, we use the term broadly. to include “classical” psychedelics as well as related substances that have substantial over ...
Mar
29
2024
Buftoad: The New Meme Coin Funding Psychedelic Research for Mental Health with AI and ...
With a mission to advance scientific exploration into the therapeutic benefits of psychedelics, Buftoad has quickly garnered attention, reaching a ...
Mar
28
2024
Optimi Health Confirms Presenting Sponsorship at the 4th - GlobeNewswire
... psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug ...
Mar
28
2024
LSD, Ecstasy Lure Traders Betting on 'Psychedelic Renaissance' - BNN Bloomberg
(Bloomberg) -- For years, investors that poured money into psychedelic stocks have wagered that their breakout moment — and the eye-watering ...
Mar
28
2024
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year ...
HOPE is supporting distribution of intravenous ketamine, currently listed by FDA on nationwide drug shortage list to qualified ketamine clinics ...
Mar
28
2024
Beckley builds case for its psychedelic depression therapy - Pharmaphorum
New data for Beckley Psytech's psychedelic therapy for treatment-resistant depression builds anticipation for a phase 2b readout later this year.
Mar
28
2024
Catholicism, Psychedelics, and Mysticism: Correlations and Displacements - MDPI
This article charts some of the conversations around psychedelics, mysticism, Catholicism, and the Catholic mystics.
Mar
28
2024
atai Life Sciences Reports Fourth Quarter and Full Year - GlobeNewswire
BPL-003 is an intranasal formulation of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) designed to fit within a two hour in-clinic treatment paradigm.
Mar
28
2024
Methyl transfer in psilocybin biosynthesis | Nature Communications
Psilocybin, the natural hallucinogen produced by Psilocybe (“magic”) mushrooms, holds great promise for the treatment of depression and several ...
Mar
28
2024
Boulder's Naropa University unveils psychedelic studies minor - The Denver Post
Boulder college planning a psychedelic studies undergraduate minor. Naropa University's courses will aim to prepare students for emerging industry ...
Mar
28
2024
Psychedelic crisis training on the way to Denver - YouTube
With the decriminalization of psilocybin and other hallucinogens in Colorado, Denver first responders will get training on how to respond to a ...
Mar
28
2024
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder ...
... psilocybin, in treatment-resistant depression (TRD); The design, launch and completion of the largest study of psilocybin ever conducted, the ...
Mar
28
2024
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co ... - Yahoo Finance
“The company is on a strong, positive trajectory to develop psilocybin treatment under Kabir Nath's principled leadership. ... psilocybin, in treatment- ...